Published in Women's Health Weekly, January 18th, 1999
When issued, the patent will grant protection to Matritech's NMP179TM, a cell-based diagnostic test which differentiates cancerous and pre-cancerous cervical cells from normal cervical cells and may be used to predict the likelihood of disease progression.
"Cervical cancer is one of the most serious malignancies in women and frequently has fatal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly